Efficacy of simvastatin and pumpkin-seed oil in the management of dietary-induced hypercholesterolemia

Pharmacological Research

Volumn 35, Issue 5, 1997, Pages 403-408

  Al Zuhair, Hana ^a   Abd El Fattah, Amal A ^b   Abd El Latif, Hekma A ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NONE

Author keywords

Aorta; Hypercholesterolemia; Norepinephrine; Pumpkin seed oil; Rabbit; Simvastatin

Indexed keywords

AMINOTRANSFERASE; ANTIOXIDANT; CHOLESTEROL; CREATINE KINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; TRIACYLGLYCEROL; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERY MUSCLE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE CONTRACTILITY; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

EID: 0031149584     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0148     Document Type: Article

References (52)

1. Lusis AJ, Navab M. Lipoprotein oxidation and gene expression in the artery wall, new opportunities for pharmacologic intervention in atherosclerosis. Biochem Pharmacol. 46:1993;2119-2126.
2. Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits. J Clin Invest. 83:1989;465-473.
3. Jayakody RL, Senaratne MPJ, Thomson ABR, Kappagoda CT. Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol. 63:1985;1206-1209.
4. Greenless C, Wainwright CL, Wadsworth RM. Vasorelaxant and antiaggregatory properties of the endothelium: a comparative study in normocholesterolaemic and hereditary and dietary hypercholesterolaemic rabbits. Br J Pharmacol. 119:1996;1470-1476.
5. Clifton PM, Noakes M, Nestel PJ. Gender and diet interactions with simvastatin treatment. Atherosclerosis. 110:1994;25-33.
6. Gey GF. On the antioxidant hypothesis with regard to atherosclerosis. Bilb Nutr Dieta. 37:1986;53-91.
7. Bruckdorfer KR. Antioxidants and cardiovascular disease. Vasc Med Rev. 6:1995;1-16.
8. Harvath S, Bedo Z. Another possibility in treatment of hyperlipidemia with peponen of natural active substance. Mediflora. 89:1988;7-8.
9. Zambo I. Analytical standardization of peponen. Mediflora. 89:1988;6-6.
10. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Eng J Med. 323:1990;1234-1238.
11. Fears R, Esmail A, Walker P, Rush WR, Ferres H. Hyperalphalipoproteinaemic activity of BRL 26314-II. Inhibition of atherosclerosis in rabbits. Biochem Pharmacol. 33:1984;219-228.
12. Bard JM, Parra HJ, Camare R, Luc G, Ziegler O, Dachet C, Bruckert E, Douste-Blazy P. A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolaemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metab Clin Exp. 41:1992;498-503.
13. Roach PD, Kerry NL, Whiting MJ, Nestel PJ. Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit. Atherosclerosis. 101:1993;157-164.
14. Fahim AT, Abd El-Fattah AA, Agha AM, Gad MZ. Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant arthritis in rats. Pharmacol Res. 31:1995;73-79.
15. Folch J, Lees M, Stanley GHS. Sloane, a simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497-509.
16. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 28:1982;2077-2080.
17. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
18. Takayama M, Iloh S, Nagazaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta. 79:1977;93-98.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem. 193:1951;265-275.
20. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
21. Firedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
22. Bourrier P, Subra JF, Chennebault JM, Spisser R, Laine P. Toxic myopathy due to hypolipidaemic agents. Therapie. 45:1990;360-365.
23. Bergmeyer HU, Bernt E. Methods of enzymatic analysis. 1974;Verlag Chemie Kleinheim Academic Press, New York.
24. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CC, Coene MC, Herman AG. Effect of hypercholesterolaemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxation in isolated arteries of control and hypercholesterolaemic rabbits. Circ Res. 58:1986;552-564.
25. Fujiwara T, Chiba S. Mechanisms of augmented vascular responses to histamine in atherosclerotic rabbit common carotid arteries. Eur J Pharmacol. 258:1994;195-205.
26. Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol. 256:1989;C591-C597.
27. Vanhoutte PM. Hypercholesterolaemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets. Eur Heart J. 12(suppl E):1991;25-32.
28. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 86:1990;2109-2116.
29. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions in pig coronary arteries during hypercholesterolemia. Circ Res. 63:1988;903-910.
30. Demacker PNM, Reijnen IGM, Katan MB, Stuyt PMJ, Stalenhoef AFH. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. Eur J Clin Invest. 21:1991;197-203.
31. Kovanen PT, Brown MS, Basu SK, Bilheimer DW, Goldstein JL. Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolaemia of cholesterol-fed rabbits. Proc Natl Acad Sci USA. 78:1981;1396-1400.
32. Goldstein JL, Kita T, Brown MS. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. N Engl J Med. 309:1983;288-296.
33. Austin MA, Breslow JL, Hennekens CH. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Ass. 260:1988;1917-1921.
34. Galle J, Mulsch A, Busse R, Bassenge E. Effects of native and oxidized low-density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 11:1991;198-203.
35. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature. 344:1990;160-162.
36. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301-308.
37. Manninen V, Tenkanen L, Koskinen P. Joint effects of serum triglyceride and LDL-cholesterol and HDL-cholesterol concentrations on coronary heart disease risk in the Helsinki Heart study. Circulation. 85:1992;37-45.
38. Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membrane. Exp Mol Pathol. 59:1993;51-57.
39. Vergani C, Stefanoni P. Efficacy and tolerability of gemfibrazil in hypercholesterolemic patients previously treated with simvastatin. Adv Ther. 10:1993;189-196.
40. Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setala K. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo) A-I. J Clin Invest. 91:1993;1665-1671.
41. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
42. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
43. Stewart-Lee AL, Ferns GA, Anggård EE. Differences in onset of impaired endothelial responses and in effects of vitamin E in the hypercholesterolemic rabbits carotid and renal arteries. J Card Pharmacol. 25:1995;906-913.
44. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 81:1984;3883-3887.
45. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res. 30:1989;1827-1834.
46. Lazos ES. Nutritional, fatty acid and oil characteristics of pumpkin and melon seeds. J Food Sci. 51:1986;1382-1383.
47. Bonaa K. Epidemiological and intervention studies on the effect of marine polyunsaturated fatty acids on blood pressure. J Intern Med. 225(suppl. 1):1989;105-110.
48. Palevic V, Milla PJ, Burnstock G. Effects of chronic vitamin E deficiency and a high polyunsaturated fatty acid diet on rat mesenteric arterial function. Br J Pharm. 116:1995;3075-3081.
49. Stewart-Lee AL, Forster LA, Nourooz-Jadeh J, Ferns GAA, Anggård AA. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Throm. 14:1994;494-499.
50. Shaw GR, Keddie JR, Pinkney J, Clarkson PN, Growcott JW, Poucher SM. Vitamin E offers protection against the impairment of endothelium-mediated relaxations in the cholesterol fed rabbit aorta but not in the hindlimb. Br J Pharmacol. 110:1993;SP159-SP159.
51. Canfield LM, Forage JW, Valenzuela JG. Carotenoids as cellular antioxidants. Proc Soc Exp Biol Med. 200:1992;260-265.
52. Ghirlanda G, Oradet A, Manto A, Lippa S, Uccioli L, Caputo S, Greco AV, Littarru GP. Evidence of Plasma CoQ-10-lowering effect by HMG-CoA reductase inhibitors: A double-blind placebo-controlled study. J Clin Pharmacol. 33:1993;226-229.